|
Interim prescribing outcomes
|
Academic detailing intervention
|
Usual care
|
|---|
|
Baseline
|
3 months
|
6 months
|
Baseline
|
3 months
|
6 months
|
|---|
|
Per protocol
|
n = 2820
|
n = 2914
|
n = 2947
|
n = 3934
|
n = 4093
|
n = 4162
|
|
Antipsychotic daily dose in the past 28 days (mean ± SD)a
|
120 ± 155
|
116 ± 136
|
122 ± 152
|
127 ± 156
|
133 ± 160
|
125 ± 156
|
|
Antipsychotic [n(%)]
|
639 (22.7%)
|
630 (21.6%)
|
624 (21.2%)
|
890 (22.6%)
|
903 (22.1%)
|
898 (21.6%)
|
|
Acetaminophen [n(%)]
|
1237 (43.9%)
|
1263 (43.3%)
|
1244 (42.2%)
|
1677 (42.6%)
|
1749 (42.7%)
|
1736 (41.7%)
|
|
Antidepressant [n(%)]
|
1436 (50.9%)
|
1478 (50.7%)
|
1495 (50.7%)
|
2000 (50.8%)
|
2085 (50.9%)
|
2102 (50.5%)
|
|
Benzodiazepine [n(%)]
|
261 (9.3%)
|
275 (9.4%)
|
273 (9.3%)
|
427 (10.9%)
|
469 (11.5%)
|
414 (9.9%)
|
|
As-treated
|
n = 2342
|
n = 2421
|
n = 2453
|
n = 4412
|
n = 4586
|
n = 4656
|
|
Antipsychotic daily dose in the past 28 days (mean ± SD)a
|
118 ± 151
|
114 ± 132
|
117 ± 145
|
128 ± 158
|
132 ± 160
|
128 ± 159
|
|
Antipsychotic [n(%)]
|
556 (23.7%)
|
548 (22.6%)
|
535 (21.8%)
|
973 (22.1%)
|
985 (21.5%)
|
987 (21.2%)
|
|
Acetaminophen [n(%)]
|
992 (42.4%)
|
1,006 (41.6%)
|
988 (40.3%)
|
1,922 (43.6%)
|
2,006 (43.7%)
|
1,992 (42.8%)
|
|
Antidepressant [n(%)]
|
1160 (49.5%)
|
1200 (49.6%)
|
1210 (49.3%)
|
2276 (51.6%)
|
2363 (51.5%)
|
2387 (51.3%)
|
|
Benzodiazepine [n(%)]
|
232 (9.9%)
|
243 (10.0%)
|
238 (9.7%)
|
456 (10.3%)
|
501 (10.9%)
|
449 (9.6%)
|
-
aAmong those who used continuously
